These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 35241571

  • 1. Neurofilament Light Chain Levels in Multiple Sclerosis Correlate With Lesions Containing Foamy Macrophages and With Acute Axonal Damage.
    van den Bosch A, Fransen N, Mason M, Rozemuller AJ, Teunissen C, Smolders J, Huitinga I.
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35241571
    [Abstract] [Full Text] [Related]

  • 2. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
    Yik JT, Becquart P, Gill J, Petkau J, Traboulsee A, Carruthers R, Kolind SH, Devonshire V, Sayao AL, Schabas A, Tam R, Moore GRW, Li DKB, Stukas S, Wellington C, Quandt JA, Vavasour IM, Laule C.
    Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative study.
    Dietmann AS, Kruse N, Stork L, Gloth M, Brück W, Metz I.
    J Neurol; 2023 Mar; 270(3):1416-1429. PubMed ID: 36372867
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS.
    Schneider R, Bellenberg B, Gisevius B, Hirschberg S, Sankowski R, Prinz M, Gold R, Lukas C, Haghikia A.
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33172960
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T, Hatzifilippou E, Arnaoutoglou M, Balogiannis S, Koutsouraki E.
    Hell J Nucl Med; 2019 Jan; 22 Suppl 2():113-121. PubMed ID: 31802051
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM, Picón C, Costa-Frossard L, Alenda R, García-Caldentey J, Espiño M, Muriel A, Álvarez-Cermeño JC.
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [Abstract] [Full Text] [Related]

  • 14. A Morphological Study of HLA-DR-Immunopositive Cells in Multiple Sclerosis Lesions and Their Implications for Pathogenesis.
    Alturkustani M, Ang LC.
    Diagnostics (Basel); 2024 Oct 08; 14(19):. PubMed ID: 39410644
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
    Martin SJ, McGlasson S, Hunt D, Overell J.
    J Neurol Neurosurg Psychiatry; 2019 Sep 08; 90(9):1059-1067. PubMed ID: 31123141
    [Abstract] [Full Text] [Related]

  • 17. Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
    Fox RJ, Raska P, Barro C, Karafa M, Konig V, Bermel RA, Chase M, Coffey CS, Goodman AD, Klawiter EC, Naismith RT, Kuhle J.
    Mult Scler; 2021 Nov 08; 27(13):2014-2022. PubMed ID: 33635141
    [Abstract] [Full Text] [Related]

  • 18. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
    Novakova L, Zetterberg H, Sundström P, Axelsson M, Khademi M, Gunnarsson M, Malmeström C, Svenningsson A, Olsson T, Piehl F, Blennow K, Lycke J.
    Neurology; 2017 Nov 28; 89(22):2230-2237. PubMed ID: 29079686
    [Abstract] [Full Text] [Related]

  • 19. Extensive acute axonal damage in pediatric multiple sclerosis lesions.
    Pfeifenbring S, Bunyan RF, Metz I, Röver C, Huppke P, Gärtner J, Lucchinetti CF, Brück W.
    Ann Neurol; 2015 Apr 28; 77(4):655-67. PubMed ID: 25612167
    [Abstract] [Full Text] [Related]

  • 20. Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions.
    de Boer A, van den Bosch AMR, Mekkes NJ, Fransen NL, Dagkesamanskaia E, Hoekstra E, Hamann J, Smolders J, Huitinga I, Holtman IR.
    Acta Neuropathol; 2024 May 21; 147(1):90. PubMed ID: 38771530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.